Justia Products Liability Opinion Summaries

Amiodarone was developed in the 1960s for the treatment of angina and was released in other countries. Amiodarone is associated with side effects, including pulmonary fibrosis, blindness, thyroid cancer, and death. In the 1970s, U.S. physicians began obtaining amiodarone from other countries for use in patients with life-threatening ventricular fibrillation or ventricular tachycardia who did not respond to other drugs. In 1985, the FDA approved Wyeth’s formulation of amiodarone, Cordarone, as a drug of last resort for patients suffering from recurring life-threatening ventricular fibrillation and ventricular tachycardia. The FDA’s “special needs” approval issued without randomized clinical trials. In 1989, the FDA described Wyeth’s promotional activities as promoting an unapproved use of the drug. In 1992, the FDA objected to promotional labeling pieces for Cordarone. Other manufacturers developed generic amiodarone, which has been available since 1998.Consolidated lawsuits alleged that plaintiffs suffered unnecessary, serious side effects when they took amiodarone, as prescribed by their doctors, for off-label use to treat atrial fibrillation, a more common, less serious, condition than ventricular fibrillation. The FDA never approved amiodarone for the treatment of atrial fibrillation, even on a special-needs basis. The court of appeal affirmed the dismissal of the lawsuits. The claims are preempted as attempts to privately enforce the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 301, regulations governing medication guides and labeling and have no independent basis in state law. The court also rejected fraud claims under California’s unfair competition law and Consumers Legal Remedy Act. View "Amiodarone Cases" on Justia Law

Appellants are individuals who bought or leased a vehicle with an emissions defeat device, and they filed individual suits that were consolidated before the same judge who presided over the multidistrict litigation and class action settlements. The jury awarded four of Appellants various amounts in compensatory damages and $25,000 each in punitive damages. The district court reduced the punitive damages award to exactly four times the amount of the compensatory damages suffered by each Plaintiff.   The Ninth Circuit vacated punitive damages awards to appellants (who are Plaintiffs who opted out of the class action) and remanded with instructions that the district court recalculate punitive damages. The panel held that the district court erred by holding that a punitive damages ratio calculation of four times the value of the compensatory damages award was the maximum punitive damages award permitted by the Constitution’s Due Process Clause. Because the panel concluded that the district court erred in applying the Gore factors, the panel next considered what award of punitive damages comported with due process for each party. The panel also concluded that it would be arbitrary and incorrect to set a different ratio between punitive damages and actual compensatory damages as to each of the Plaintiffs under the circumstances of this case. The panel, therefore, vacated the punitive damages awards to each appellant and remanded with instructions that the district court recalculate punitive damages in an amount equal to eight times the actual compensatory damages determination. View "TIMOTHY RILEY V. VOLKSWAGEN GROUP OF AMERICA, I" on Justia Law

Plaintiff regularly used Roundup on his lawn for about 30 years until 2016. Around 2016, Plaintiff was diagnosed with malignant fibrous histiocytoma, which he believes was linked to the compound glyphosate, the main chemical ingredient in Roundup. Plaintiff filed suit against Monsanto, the manufacturer of Roundup. In his four-count complaint, Plaintiff alleged strict liability for a design defect under Georgia law (Count I); strict liability for failure to warn under Georgia law Count II); negligence under Georgia law (Count III); and breach of implied warranties under Georgia law (Count IV).   On appeal, the Eleventh Circuit was tasked with deciding whether the district court erred in concluding that Plaintiff’s failure to warn claim was preempted under Federal Insecticide, Fungicide, and Rodenticide Ac (FIFRA) because the Environmental Protection Agency’s (EPA) had classified glyphosate as not likely to be carcinogenic to humans and approved the Roundup label. The Eleventh Circuit concluded it did and reversed the district court’s ruling. The court held that Plaintiff’s Georgia failure to warn claim is not preempted by the federal requirements under the FIFRA or the EPA actions pursuant to it. View "John D. Carson v. Monsanto Company" on Justia Law

Plaintiffs sued Nissan, alleging the transmission in a 2013 Nissan Sentra they purchased was defective, bringing statutory claims under the Song-Beverly Consumer Warranty Act (Civ. Code 1790) and a common law fraud claim alleging that Nissan, by fraudulently concealing the defects, induced them to purchase the car. The trial court dismissed the fraudulent inducement claim as barred by the “economic loss rule.” The court also struck the plaintiffs’ request for punitive damages.The court of appeal reversed. Under California law, the economic loss rule does not bar the fraudulent inducement claim. The fraudulent inducement exception to the economic loss rule applies; fraudulent inducement is a viable tort claim under California law. The plaintiffs adequately pleaded that the transmissions installed in numerous Nissan vehicles (including the one they purchased) were defective; Nissan knew of the defects and the hazards they posed; Nissan had exclusive knowledge of the defects but intentionally concealed and failed to disclose that information; Nissan intended to deceive plaintiffs by concealing known transmission problems; plaintiffs would not have purchased the car if they had known of the defects; and plaintiffs suffered damages in the form of money paid to purchase the car. View "Dhital v. Nissan North America, Inc." on Justia Law

Plaintiff-appellant Chad Defries suffered injuries while riding a Yamaha dirt bike. He sued the U.S. distributor of that dirt bike, defendant-respondent Yamaha Motor Corporation, U.S.A. (Yamaha), among others, asserting that the accident was caused by a throttle assembly that fell off the handlebar as he was riding. The jury found in Yamaha’s favor, and the trial court later awarded Yamaha costs. On appeal, Defries contended, among other things, that the trial court erroneously denied his request to instruct the jury that Yamaha was liable for its dealer’s negligent assembly of the dirt bike, a ruling that limited Defries’s negligence cause of action to Yamaha’s own negligence. The Court of Appeal found that California law, however, placed “responsibility for defects, whether negligently or nonnegligently caused, on the manufacturer of the completed product . . . regardless of what part of the manufacturing process the manufacturer chooses to delegate to third parties.” The same principle applied to distributors. And as the distributor of a completed product, Yamaha “cannot delegate its duty . . . [and thus] cannot escape liability on the ground that the defect in [Defries’s bike] may have been caused by something one of its authorized dealers did or failed to do.” If the dealer negligently assembled the product, Yamaha was jointly liable for damages caused by that negligence. Because the requested instruction should have been given, the Court of Appeal reversed the judgment on the negligence cause of action, and affirmed in all other respects. View "Defries v. Yamaha Motor Corporation, U.S.A." on Justia Law

Michael Galier brought a negligence and products liability action against Defendant-Appellant Murco Wall Products, Inc., a Texas manufacturer. Galier alleged exposure to Murco's products caused him to contract mesothelioma. The Oklahoma County District Court denied Murco's motion to dismiss for lack of personal jurisdiction and, following a jury trial, granted judgment to Galier. The Court of Civil Appeals affirmed. The Oklahoma Supreme Court denied certiorari. The United States Supreme Court granted certiorari, vacated the Court of Civil Appeals' decision, and remanded for reconsideration in light of Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 137 S. Ct. 1773 (2017). The Court of Civil Appeals reaffirmed the district court. The Oklahoma Supreme Court previously granted certiorari to address whether the Court of Civil Appeals properly found that Oklahoma possesses specific personal jurisdiction over Murco, and determined that it did: " 'relationship among the defendant, the forum, and the litigation' "--supported specific jurisdiction. View "Galier v. Marco Wall Products" on Justia Law

Olson and Zdroik sustained injuries while volunteering at municipal fireworks displays in 2018. Fireworks distributed by Spielbauer Fireworks exploded prematurely at both events, severely burning the two. Both towns used teams of volunteers to operate their Fourth of July displays. Olson opened and closed a bin from which other volunteers retrieved fireworks during the Rib Lake show. Zdroik worked at the Land O’Lakes event as a “shooter,” manually lighting the fuses on mortar shells.Spielbauer’s insurer, T.H.E. Insurance, contested coverage under Spielbauer’s general and excess liability policies, which stated: This policy shall NOT provide coverage of any kind ... for any claims arising out of injuries or death to shooters or their assistants hired to perform fireworks displays or any other persons assisting or aiding in the display of fireworks whether or not any of the foregoing are employed by the Named Insured, any shooter or any assistant. The issue was whether the exclusion extends to all volunteers or only to those assisting hired shooters or hired assistants.The Seventh Circuit affirmed, in favor of T.H.E. Insurance. The Shooters Endorsement plainly and unambiguously excludes from coverage hired shooters and their hired assistants and “any other persons” who assist the fireworks display, regardless of whether they assist hired persons. View "T.H.E. Insurance Co. v. Olson" on Justia Law

This case presented a question of whether Mississippi courts had personal jurisdiction over a South Korean battery manufacturer whose goods were in the stream of commerce in Mississippi. The Mississippi Plaintiff, Melissa Dilworth, was seriously injured when one of LG Chem Ltd.’s (LG Chem) lithium-ion batteries exploded in her vaping pen. LG Chem and its Georgia-based subsidiary, LG Chem America, argued successfully before the circuit court that they lacked sufficient minimum contacts with Mississippi to satisfy the constitutional standard for exercising personal jurisdiction over nonresident defendants. On appeal, the Mississippi Supreme Court found that manufacturer LG Chem purposefully availed itself of the market for its product in Mississippi such that the exercise of specific personal jurisdiction comported with due process principles. The Supreme Court also found that dismissal of subsidiary LG Chem America was premature; therefore, judgment was reversed and the matter remanded for jurisdictional discovery. View "Dilworth v. LG Chem, Ltd. et al." on Justia Law

The United States Court of Appeals for the Eleventh Circuit certified a question of law to the Alabama Supreme Court. Dr. Dino Ferrante, a gastroenterologist, prescribed LIALDA, which is manufactured by Shire U.S., Inc., and Shire, LLC (referred to collectively as "Shire"), to help patient Mark Blackburn with his Crohn's disease. "LIALDA is the brand name for Shire's mesalamine drug, which is an anti-inflammatory drug specifically aimed at the gut. LIALDA is not approved by the FDA to treat Crohn's, but it is approved to treat ulcerative colitis, Crohn's 'sister' disease." After taking LIALDA for between 12 to 16 months, Blackburn discovered that he had developed kidney disease, specifically advanced chronic interstitial nephritis, which had resulted in irreversible scarring and had diminished his kidney function to 20% of normal capacity. As a result, Blackburn is awaiting a kidney transplant. The federal appellate court asked: (1) consistent with the learned intermediary doctrine, may a pharmaceutical company's duty to warn include a duty to provide instructions about how to mitigate warned-of risks?; and (2) might a plaintiff establish that a failure to warn caused his injuries by showing that his doctor would have adopted a different course of testing or mitigation, even though he would have prescribed the same drug? The Supreme Court answered both questions in the affirmative. View "Blackburn v. Shire U.S., Inc., et al." on Justia Law

Plaintiff appealed from the district court’s grant of summary judgment in favor of a mixed group of domestic and foreign corporations, (collectively, “the defendants”), in a product liability action stemming from a motorcycle accident and allegedly defective helmet. Plaintiff contended that the district court erroneously excluded the testimony of her expert witness, after finding his testimony based on novel and untested theories unreliable.   In the district court proceedings, defendant HJC Corporation (“HJC”), a foreign corporation organized under the laws of, and principally operating within, South Korea, moved separately for summary judgment based on a lack of personal jurisdiction. The district court denied this motion as moot, after granting summary judgment to all the defendants on the merits.   The Eleventh Circuit affirmed the district court’s grant of Defendants’ motion to exclude Plaintiff’s expert’s testimony. Because the district court properly excluded Plaintiff’s expert’s testimony, the court affirmed the district court’s grant of summary judgment in favor of Defendants. The court reversed its denial of HJC’s motion for summary judgment. The court concluded that the district court erred by failing to conduct a veil piercing or alter-ego analysis with respect to HJC and HJCA for personal jurisdiction purposes. The court agreed with HJC that the district court erred by failing to address HJC’s jurisdictional motion before reaching the merits of Defendants’ summary judgment motion. View "Sheila A. Knepfle v. J & P Cycles, LLC, et al" on Justia Law